Evexia Wealth LLC has disclosed its latest investment holdings in a recent SEC filing, revealing a total value of over $360 million as of September 30, 2026. This significant update provides insights into the firm's strategic positioning within the asset management industry.

Founded in Stevens Point, Wisconsin, Evexia Wealth LLC operates in the financial services sector. The firm specializes in managing investments and providing financial advisory services. According to its recent filings, the company has been consistently reporting its holdings through various SEC forms, including the 13F-HR.

The latest filing, accession number 0001951757-26-001809, indicates that Evexia Wealth reported a total of 80 holdings valued at approximately $360,310,272. The filing was made on November 5, 2026, and covers the period ending on September 30, 2026. The Chief Compliance Officer, Jenna Laws, signed the report, underscoring the firm's commitment to regulatory compliance.

Among the notable investments listed in the filing are major companies such as Abbott Laboratories, AbbVie Inc., and Amazon.com Inc. These selections reflect Evexia's strategy to invest in established firms across various sectors, including healthcare and technology. The firm's investment discretion is marked as 'SOLE' for all reported holdings, indicating that Evexia has full control over these investment decisions.

This update may affect various stakeholders, including investors and competitors in the asset management space. As firms analyze Evexia's investment choices, they may adjust their strategies to remain competitive. The asset management industry continues to experience shifts as firms like Evexia adapt to market trends and investor demands.

Looking ahead, it remains to be seen how Evexia Wealth will adjust its portfolio in future filings. The company has a history of regular reporting, and its next filing is anticipated to provide further insights into its investment strategies and market positioning.